Fresenius SE
From Wikipedia, the free encyclopedia
| Fresenius SE | |
|---|---|
 |
|
| Type | Public |
| Founded | 1912 |
| Headquarters |  Bad Homburg, Germany |
| Key people | Ulf M. Schneider (Chairman of the management board), Gerd Krick (Chairman of the supervisory board) |
| Industry | Health care |
| Products | Kidney dialysis Infusion pumps and drugs hospitals medical care of patients at home |
| Revenue | €10.777 billion (2006)[1] |
| Employees | 104,800 (2006)[1] |
| Website | www.fresenius.se |
Fresenius SE (FWB: FREG) is a health care company with approximately 100,000 employees, based in Bad Homburg, Germany.
Fresenius consists of three wholly-owned business units, Fresenius Biotech, Fresenius Kabi and Fresenius ProServe, and holds approximately 37% of Fresenius Medical Care.[2]
The American branch is headquartered in Waltham, Massachusetts.
On 2007-07-16, the company completed its conversion from an Aktiengesellschaft (AG -- German public limited company) to a Societas Europaea, a European Union-wide equivalent.[3]
[edit] References
- ^ a b Fresenius SE. Fresenius Annual Report 2006. Retrieved on 2007-08-12.
- ^ Fresenius Medical Care. Capital structure. Retrieved on 2007-08-12.
- ^ Fresenius SE (2007-07-16). Fresenius completes conversion into a European Company (SE). Retrieved on 2007-08-12.
[edit] External links
|
|||||
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 |
This German corporation or company article is a stub. You can help Wikipedia by expanding it. |
